Launching a new product is hard. Executing that launch with limited people and financing is even harder.
For a new drug, the first 6 months after launch is critical. That’s because after this initial “honeymoon” period, prescription writing starts to drop off significantly.
From R&D and clinical trials to the number of people it employs, biopharma helps drive our economy. Biopharma Adds Big Boost to US Economy
AI, digital infrastructure, supply chain vulnerability, emphasis on data. Although accelerated by the pandemic, these trends have been gathering momentum within pharma long before 2020. Infographic: The New Normal/4 Pharma Trends
Instant access to market research insights is critical for any brand team. Yet many teams wait days, if not weeks, to acquire the data they need to support decisions. These delays cause projects to run long and prevent teams from making agile changes to their go-to-market activities.
Launching a new pharma product is challenging for any company, but doing so at a small organization comes with its own set of issues. Here are 4 tips smaller companies can use to optimize resources for their next launch.